
Wouter Zandee
@w_zandee
Followers
65
Following
120
Media
9
Statuses
121
Endocrinologist UMCG. Loves to run. Eat, sleep, work, train, repeat. Tweets are my own.
Joined May 2011
RT @EJEndo: #CoMICWednesday #EJECoMICs Ep 49: NEW @EJEndo paper: Partial versus Radical Adrenalectomy in Hereditary Pheochromocytomas .Watc….
0
6
0
RT @chana_weinstock: Our @FDAOncology approval summary for belzutifan, a first-in-class HIF inhibitor which is the first drug approved for….
0
31
0
Active Surveillance can especially be considered for microPTC. However tumors adjacent to the laryngeal nerve. ( and younger patients ( are not the best candidates.
liebertpub.com
Background: We showed previously that subclinical low-risk papillary thyroid microcarcinoma (PTMC) could be observed without immediate surgery. Patient age is an important prognostic factor of...
0
0
2
RT @wijmenga_cisca: Hoe kan het toch dat een advies om de centra voor aangeboren hartafwijkingen in Leiden, Rotterdam en Groningen te conce….
0
271
0
RT @EndoCancer: From the 2020 Impact Factor Collection: 'Peptide receptor radionuclide therapy in gastroenteropancreatic NEN G3: a multicen….
0
1
0
A great @net_connectinfo collaboration!.
Not sure what to do with those advanced well diff grade 3 NETs? Well, this excellent study will be of great interest to you. Excellent addition to the literature. Well done! @louis_demestier @JHernando3 @Ja_Capdevila @w_zandee and others
0
0
2
We report patients with stable disease and CS with symptoms despite SSA who were treated with PRRT. PRRT improved symptoms in this group with severe CS!.
PRRT for NETs - not just tumor control but also effective for control of carcinoid syndrome symptoms. Excellent work by @w_zandee et al. Clinically meaningful reduction in symptom burden. Definitely the kind of data we clinicians love to see.
0
1
8
Immunology for dummies.
[Random loose mRNA lying around in a deltoid]. Nobody:. Ribosome: let me go ahead and transcribe this. Macrophage: Yo, check out this cool spike I found. T-cell: wtf is that? Get rid of it. Where’s Bob?. B-cell: yes?. T-cell: If it ever shows up here again. B-cell: yes mam.
0
0
1
Great team!.
#Somatostatin analogs are regularly used as first line for GEP-#NETs. But what about #panNETs with Ki-67 Scores above 10%?.@cives_mauro, @Prof_M_C, @JHernando3, @T_AlonsoGordoa, @w_zandee and colleagues have explored this. The results may surprise some!.
1
1
3
SSTR-negative NET patients continue to have a worse prognosis compared to SSTR-positive NET patients despite receiving more aggressive treatment.
Now online @EndoCancer: excellent work from our Swiss fellow Julie Refardt 👏 on the worse prognosis of patients with somatostatin receptor-negative NETs #netcancer @ErasmusMC
0
0
3
RT @NeuroEndoTalk: 1/2 . “#Carcinoid” syndrome revisited. A meta-analysis on the “treatment for carcinoid syndrome” undertaken at @Erasmu….
erc.bioscientifica.com
Carcinoid syndrome (CS) is a debilitating disease caused by functional neuroendocrine tumors. Several treatment options are available to alleviate the hormonal symptoms, but their relative efficacy...
0
4
0